OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 74 filers reported holding OPHTHOTECH CORP in Q4 2017. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $20,000 | -9.1% | 14,000 | -22.2% | 0.00% | – |
| Q4 2018 | $22,000 | -53.2% | 18,000 | -10.0% | 0.00% | – |
| Q3 2018 | $47,000 | -14.5% | 20,000 | 0.0% | 0.00% | – |
| Q2 2018 | $55,000 | +12.2% | 20,000 | +11.1% | 0.00% | – |
| Q1 2018 | $49,000 | -12.5% | 18,000 | 0.0% | 0.00% | – |
| Q4 2017 | $56,000 | +3.7% | 18,000 | -5.3% | 0.00% | – |
| Q3 2017 | $54,000 | +10.2% | 19,000 | 0.0% | 0.00% | – |
| Q2 2017 | $49,000 | -30.0% | 19,000 | 0.0% | 0.00% | – |
| Q1 2017 | $70,000 | -62.0% | 19,000 | -50.0% | 0.00% | -100.0% |
| Q4 2016 | $184,000 | -79.0% | 38,000 | +100.0% | 0.00% | -80.0% |
| Q3 2016 | $876,000 | -9.7% | 19,000 | 0.0% | 0.01% | -16.7% |
| Q2 2016 | $970,000 | +20.8% | 19,000 | 0.0% | 0.01% | +20.0% |
| Q1 2016 | $803,000 | -46.2% | 19,000 | 0.0% | 0.01% | -44.4% |
| Q4 2015 | $1,492,000 | +93.8% | 19,000 | 0.0% | 0.01% | +80.0% |
| Q3 2015 | $770,000 | -26.0% | 19,000 | -5.0% | 0.01% | 0.0% |
| Q2 2015 | $1,041,000 | +11.8% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $931,000 | +3.8% | 20,000 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $897,000 | +15.1% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $779,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,103,981 | $44,734,000 | 25.02% |
| Novo Holdings A/S | 4,910,487 | $198,973,000 | 20.56% |
| JHL Capital Group LLC | 3,265,000 | $132,298,000 | 14.62% |
| AlpInvest Partners B.V. | 111,519 | $4,519,000 | 8.90% |
| Opaleye Management Inc. | 105,000 | $4,255,000 | 2.09% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $653,000 | 2.05% |
| IMA Wealth, Inc. | 66,061 | $2,623,000 | 1.66% |
| WILLIAM HARRIS INVESTORS INC | 143,022 | $5,795,000 | 1.64% |
| Orbimed Advisors | 1,923,500 | $77,940,000 | 0.79% |
| Overbrook Management Corp | 117,807 | $4,774,000 | 0.74% |